| P50 | author | Dana Horáková | Q38800109 |
| | Bianca Weinstock-Guttman | Q41674629 |
| | Michaela Tyblova | Q51063022 |
| | Tomáš Uher | Q83597921 |
| | Helena Posova | Q85729148 |
| P2093 | author name string | Robert Zivadinov | |
| | Jan Krasensky | |
| | Manuela Vaneckova | |
| | Zdenek Seidl | |
| | Murali Ramanathan | |
| | Richard W Browne | |
| | Eva Havrdova | |
| | Kelly Fellows | |
| P2860 | cites work | The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study | Q28141600 |
| | Multiple sclerosis as a vascular disease | Q28239335 |
| | Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 |
| | Thalamic atrophy is associated with development of clinically definite multiple sclerosis | Q30619701 |
| | Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis | Q33819382 |
| | The immune system in atherosclerosis | Q34164644 |
| | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study | Q34483022 |
| | ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet | Q34657417 |
| | Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus | Q35114943 |
| | Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis | Q35586845 |
| | Blood-brain barrier disruption in multiple sclerosis | Q35603711 |
| | Inflammatory cortical demyelination in early multiple sclerosis | Q35764685 |
| | Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease | Q35986336 |
| | Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement | Q36163180 |
| | CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions | Q36384816 |
| | The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis | Q36832860 |
| | Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy | Q37368148 |
| | Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms | Q37776054 |
| | Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis | Q37866321 |
| | An adverse lipid profile is associated with disability and progression in disability, in people with MS. | Q38211841 |
| | HDL and cholesterol handling in the brain | Q38218439 |
| | Role of the blood-brain barrier in multiple sclerosis | Q38272288 |
| | Vascular comorbidities in the onset and progression of multiple sclerosis. | Q38278157 |
| | A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis. | Q41734452 |
| | Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism? | Q42791504 |
| | Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis | Q43846446 |
| | Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis | Q44051992 |
| | Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid | Q45172407 |
| | Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. | Q47788747 |
| | Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b | Q48132175 |
| | The discovery of oligoclonal bands: a 50-year anniversary | Q49047601 |
| | Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event. | Q51062974 |
| | Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 |
| | Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. | Q52149416 |
| | Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease | Q56899909 |
| | Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes | Q61037588 |
| | Isoelectric focusing in an immobilized pH gradient for the detection of intrathecal IgG in cerebrospinal fluid: sensitivity and specificity for the diagnosis of multiple sclerosis | Q72631979 |
| | Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli | Q73554737 |
| | Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay | Q79447864 |
| P433 | issue | 10 | |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 2010-2018 | |
| P577 | publication date | 2015-08-04 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients | |
| P478 | volume | 56 | |